The drug will be funded on the NHS to treat ulcerative colitis under certain conditions

The deal gives GSK access to IDEAYA’s MAT2A, Pol Theta, and Werner Helicase programmes

The move follows data from the RECOVERY trial showing no beneficial effect of the drug in patients hospitalised […]

Novartis takes aim at Eli Lilly with Cosentyx FDA nod in spondyloarthritis kblankenship Tue, 06/16/2020 – 21:47

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT

Updated Date: Tue, 09 Jun 2020 00:00:00 EDT

U.K. endorses dexamethasone in COVID-19 hours after groundbreaking data release esagonowsky Tue, 06/16/2020 – 15:18